[HTML][HTML] Peptide receptor radionuclide therapy (PRRT): innovations and improvements

E Merola, CM Grana - Cancers, 2023 - mdpi.com
Simple Summary This article discusses the use of peptide receptor radionuclide therapy
(PRRT) as a key treatment method for advanced, unresectable neuroendocrine tumors. It …

[PDF][PDF] Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements. Cancers 2023, 15, 2975

E Merola, CM Grana - 2023 - pdfs.semanticscholar.org
Neuroendocrine neoplasms (NENs) are tumors originating from neuroendocrine cells
distributed throughout the human body. With an increasing incidence over the past few …

Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements

E Merola, CM Grana - Cancers, 2023 - pubmed.ncbi.nlm.nih.gov
Neuroendocrine neoplasms (NENs) are tumors originating from neuroendocrine cells
distributed throughout the human body. With an increasing incidence over the past few …

Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements.

E Merola, CM Grana - Cancers, 2023 - europepmc.org
Neuroendocrine neoplasms (NENs) are tumors originating from neuroendocrine cells
distributed throughout the human body. With an increasing incidence over the past few …

Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements

E Merola, CM Grana - Cancers, 2023 - search.proquest.com
Neuroendocrine neoplasms (NENs) are tumors originating from neuroendocrine cells
distributed throughout the human body. With an increasing incidence over the past few …

[HTML][HTML] Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements

E Merola, CM Grana - Cancers, 2023 - ncbi.nlm.nih.gov
Neuroendocrine neoplasms (NENs) are tumors originating from neuroendocrine cells
distributed throughout the human body. With an increasing incidence over the past few …

Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements.

E Merola, CM Grana - Cancers, 2023 - search.ebscohost.com
Abstract Simple Summary: This article discusses the use of peptide receptor radionuclide
therapy (PRRT) as a key treatment method for advanced, unresectable neuroendocrine …